DXI Capital (TSE:DXI.H) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
DXI Capital Corp. has submitted a comprehensive initial proposal to the TSX Venture Exchange for its planned acquisition of V.V.T. Med Ltd. and Exiteam Acquisition Corp., aiming to finalize the deal by the end of Q1 2025. This strategic move is designed to help DXI transition into the life sciences sector, leveraging VVT’s innovative technology for varicose vein treatment. Further progress updates will be announced as they occur.
For further insights into TSE:DXI.H stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ZMI, TBAL: 2 Canadian Balanced ETFs to Shield Your Returns
- Class Action Lawsuit Against Paragon 28, Inc. (NYSE:FNA)
- 3 Penny Stocks to Watch Now, 11/29/24
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
